ACCELERATING THE FUTURE OF MEDICINE FOR EVERYONE
LIVE

Serial Number

97933737

Owner

CARE ACCESS RESEARCH LLC

Attorney

Rachelle A. Dubow, Esq.

Filing Date

May 12, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ACCELERATING THE FUTURE OF MEDICINE FOR EVERYONE Trademark

Serial Number: 97933737

ACCELERATING THE FUTURE OF MEDICINE FOR EVERYONE is a trademark filed by CARE ACCESS RESEARCH LLC on May 12, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

CARE ACCESS RESEARCH LLC (7 trademarks)

33 Arch Street, 17th Floor
Boston, MA 02110

Entity Type: 16

Trademark Details

Filing Date

May 12, 2023

Registration Date

Not Registered

Published for Opposition

April 2, 2024

Goods & Services

Medical and scientific research in the nature of conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Consulting services for others in the field of design, planning, and implementation project management of clinical trials

Recruitment advertisement services, namely, contacting physicians for the purpose of recruiting patients for participation in clinical trials for the testing of drugs by means of direct methods of marketing, namely, e-mail marketing, SMS messaging, electronic medical record (EMR) messaging, in-clinic communications, in-clinic promotional material, and telephone calls, and indirect methods of marketing communications, namely, social media, search engine marketing, inquiry marketing, internet marketing, mobile marketing, blogging and other forms of passive, sharable or viral communications channels of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 27, 2026 EXRA
SOU EXTENSION 4 GRANTED
May 26, 2026 EX4G
SOU EXTENSION 4 FILED
May 26, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
May 26, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 26, 2025 EXRA
SOU EXTENSION 3 GRANTED
Nov 25, 2025 EX3G
SOU EXTENSION 3 FILED
Nov 25, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 25, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jun 2, 2025 EX2G
SOU EXTENSION 2 FILED
Jun 2, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 2, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Dec 4, 2024 EX1G
SOU EXTENSION 1 FILED
Dec 4, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 4, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 4, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 2, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 28, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 27, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 12, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 12, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 12, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 6, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2023 NWOS
NEW APPLICATION ENTERED
May 16, 2023 NWAP